Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Clonal Dynamics During Venetoclax Treatment for CLL
NCT03986034Phase 2Recruiting
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jun 2019
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by National Heart, Lung, and Blood Institute. Started Jun 2019; status: recruiting.
02
Drugs
venetoclax
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT03986034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03986034.